- Glial fibrillary acidic protein (GFAP): This antigen is mentioned in the context of immunohistochemical analysis, where it is positive in the patient's case, indicating a glial neoplasm.

- IDH1 R132H: The article discusses the negative immunohistochemical analysis for IDH1 R132H, which is consistent with a wild-type ("de novo") glioblastoma. The absence of IDH1 expression is associated with a poor prognosis and a mean survival of 10-15 months.
